Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-17T07:23:33.110Z Has data issue: false hasContentIssue false
  • English
  • Français

A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania

Published online by Cambridge University Press:  16 April 2020

R.M. Jones ,
C. Thompson  and
I. Bitter
R.M. Jones*
Affiliation:
Mental Health Group, University of Southampton, Southampton, UK
C. Thompson
Affiliation:
Mental Health Group, University of Southampton, Southampton, UK
I. Bitter
Affiliation:
E. Lilly Regional Operations, Vienna, Austria Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary
*
*Corresponding author. Present address. Department of Psychiatry, Royal South Hants Hospital, Brittons Terrace, Southampton, S014 OYD, UK. Tel.: +44 2380 79 6581. E-mail address:[email protected] (R.M. Jones).
Get access

Abstract

Second generation antipsychotic agents are increasingly used in the management of acute mania. A systematic review of the efficacy and safety of these agents, as both monotherapy and in combination with mood stabilisers, was performed to establish the evidence for their use. Randomised controlled trials (RCTs) were critically appraised in more detail than studies that presented lower levels of evidence such as case reports, case series and open label follow up studies. We found 11 RCTs reporting on patients treated with second generation antipsychotics for acute bipolar mania, of which three included randomisation between the second generation antipsychotic and placebo, and eight between a mood stabiliser combined with either the second generation antipsychotic or placebo. Data from non-randomised trials is also presented.

Keywords

ManiaBipolar disorderSecond generationAntipsychoticEfficacySafety
Type
Review
Information
European Psychiatry , Volume 21 , Issue 1 , January 2006 , pp. 1 - 9
Copyright
Copyright © Elsevier SAS 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aubry, JMSimon, AEBertschy, GPossible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J. Clin. Psychiatry 2000;61(9):649–655.CrossRefGoogle ScholarPubMed
Baker, RWMilton, DRStauffer, VLGelenberg, ATohen, MPlacebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania. J. Affect. Disord. 2003;73(1–2):147–153.CrossRefGoogle Scholar
Baldassano, CFBallas, CDatto, SMKim, DLittman, LO'Reardon, Jet al.Ziprasidone-associated mania: a case series and review of the mechanism. Bipolar Disord. 2003;5(1):72–75.CrossRefGoogle ScholarPubMed
Barkin, JSPais, VM Jr.Gaffney, MFInduction of mania by risperidone resistant to mood stabilizers. J. Clin. Psychopharmacol. 1997;17(1):57–58.Google ScholarPubMed
Bech, PBolwig, TKramp, PRafaelsen, OBech–Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr. Scand. 1979;59:420–430.CrossRefGoogle ScholarPubMed
Benazzi, FOlanzapine-induced psychotic mania in bipolar schizoaffective disorder. Can. J. Psychiatry 1999;44(6):607–608.Google ScholarPubMed
Berk, MIchim, LBrook, SOlanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int. Clin. Psychopharmacol. 1999;14(6):339–343.CrossRefGoogle ScholarPubMed
Calabrese, JRKimmel, SEWoyshville, MJRapport, DJFaust, CJThompson, PA, et al.Clozapine for treatment-refractory mania. Am. J. Psychiatry 1996;153(6):759–764.Google ScholarPubMed
Chang, KDKetter, TAMood stabilizer augmentation with olanzapine in acutely manic children. J. Child Adolesc. Psychopharmacol. 2000;10(1):45–49.CrossRefGoogle ScholarPubMed
Chanpattana, WCombined ECT and clozapine in treatment-resistant mania. J. ECT 2000;16(2):204–207.CrossRefGoogle ScholarPubMed
Cookson, JUse of antipsychotic drugs and lithium in mania. Br. J. Psychiatry 2001;178(Suppl 41):S148–S156.CrossRefGoogle ScholarPubMed
Davis, RRisch, SCZiprasidone induction of hypomania in depression? Am. J. Psychiatry 2002;159(4):673–674.CrossRefGoogle ScholarPubMed
Delbello, MPSchwiers, MLRosenberg, HLStrakowski, SMA double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry 2002;41(10):1216–1223.CrossRefGoogle ScholarPubMed
Diaz, SFMania associated with risperidone use. J. Clin. Psychiatry 1996;57(1):41–42.Google ScholarPubMed
Dennehy, EBDoyle, KSuppes, TThe efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting. Int. Clin. Psychopharmacol. 2003;18(3):143–145.Google ScholarPubMed
Dunayevich, EStrakowski, SMQuetiapine for treatment-resistant mania. Am. J. Psychiatry 2000;157(8):1341.CrossRefGoogle ScholarPubMed
Frazier, JABiederman, JTohen, MFeldman, PDJacobs, TGToma, V, et al.A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. 2001;11(3):239–250.CrossRefGoogle ScholarPubMed
Frazier, JAMeyer, MCBiederman, JWozniak, JWilens, TESpencer, TJ, et al.Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J. Am. Acad. Child Adolesc. Psychiatry 1999;38(8):960–965.CrossRefGoogle Scholar
Frye, MAKetter, TAAltshuler, LLDenicoff, KDunn, RTKimbrell, TA, et al.Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J. Affect. Disord. 1998;48(2–3):91–104.CrossRefGoogle ScholarPubMed
Ghaemi, SNKatzow, JJThe use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann. Clin. Psychiatry 1999;11(3):137–140.CrossRefGoogle Scholar
Ghaemi, SNSachs, GSBaldassano, CFTruman, CJAcute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can. J. Psychiatry 1997;42(2):196–199.CrossRefGoogle ScholarPubMed
Gonzalez-Pinto, ALalaguna, BMosquera, FPerez de Heredia, JLGutierrez, MEzcurra, J, et al.Use of olanzapine in dysphoric mania. J. Affect. Disord. 2001;66(2–3):247–253.CrossRefGoogle ScholarPubMed
Goodnick, PJRisperidone treatment of refractory acute mania. J. Clin. Psychiatry 1995;56(9):431–432.Google ScholarPubMed
Green, AITohen, MPatel, JKBanov, MDuRand, CBerman, I, et al.Clozapine in the treatment of refractory psychotic mania. Am. J. Psychiatry 2000;157(6):982–986.CrossRefGoogle ScholarPubMed
Guezelcan, Y Risperidone may induce mania. Psychopharmacology (Berl.) 2000;:162 (June).Google Scholar
Henry, CDemotes-Mainard, JOlanzapine-induced mania in bipolar disorders. J. Psychiatry Neurosci. 2002;27(3):200–201.Google ScholarPubMed
John, VRapp, MPies, RAggression, agitation, and mania with olanzapine. Can. J. Psychiatry 1998;43(10):1054.Google ScholarPubMed
Jonkers, FDe Haan, LOlanzapine-induced obsessive–compulsive symptoms in a patient with bipolar II disorder. Psychopharmacology (Berl.) 2002;162(1):87–88.CrossRefGoogle Scholar
Keck, PE Jr.Versiani, MPotkin, SWest, SAGiller, EIce, KZiprasidone in the treatment of acute bipolar mania: a 3-week, placebo-controlled, double-blind, randomized trial. Am. J. Psychiatry 2003;160(4):741–748.CrossRefGoogle Scholar
Kupfer, DSartorius, NThe usefulness and use of second-generation antipsychotic medications. Review of evidence and recommendations by a Task Force of the World Psychiatric Association. Curr Opin Psychiatry;15(Suppl 1) S3–S5.Google Scholar
London, JAMania associated with olanzapine. J. Am. Acad. Child Adolesc. Psychiatry 1998;37(2):135–136.CrossRefGoogle ScholarPubMed
Lu, BYLundgren, REscalona, PRRoberts, BBA case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics. J. Clin. Psychiatry 2002;63(12):1185–1186.CrossRefGoogle ScholarPubMed
Lykouras, LGournellis, RAngelopoulos, EManic symptoms induced by olanzapine. Eur. Neuropsychopharmacol. 2001;11(2):97–98.CrossRefGoogle ScholarPubMed
Masi, GMucci, MMillepiedi, SClozapine in adolescent inpatients with acute mania. J. Child Adolesc. Psychopharmacol. 2002;12(2):93–99.CrossRefGoogle ScholarPubMed
Meehan, KZhang, FDavid, STohen, MJanicak, PSmall, J, et al.A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J. Clin. Psychopharmacol. 2001;21(4):389–397.CrossRefGoogle ScholarPubMed
McElroy, SLFrye, MDenicoff, KAltshuler, LNolen, WKupka, R, et al.Olanzapine in treatment-resistant bipolar disorder. J. Affect. Disord. 1998;49(2):119–122.CrossRefGoogle ScholarPubMed
Monreal, JAStaner, LActas Esp. Psiquiatr. 2001;29(5):349–350 [Mania, parkinson disease and risperidone. Case report].Google Scholar
Nolan, BPSchulte, JJ Jr.Mania associated with initiation of ziprasidone. J. Clin. Psychiatry 2003;64(3):336.CrossRefGoogle ScholarPubMed
Namjoshi, MARajamannar, GJacobs, TSanger, TMRisser, RTohen, MF, et al.Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. J. Affect. Disord. 2002;69(1–3):109–118.CrossRefGoogle ScholarPubMed
Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 2002;159(4 Suppl):1–50.CrossRefGoogle Scholar
Pozo, PAlcantara, AGMania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment. J. Psychiatry Neurosci. 1998;23(5):309–310.Google Scholar
Sachs, GSGrossman, FGhaemi, SNOkamoto, ABowden, CLCombination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am. J. Psychiatry 2002;159(7):1146–1154.CrossRefGoogle ScholarPubMed
Sachs, GSPrintz, DJKahn, DACarpenter, DDocherty, JPThe Expert Consensus Guideline Series: medication treatment of bipolar disorder 2000. Postgrad. Med. 2002;Spec No:1–104.Google Scholar
Sajatovic, MDiGiovanni, SKBastani, BHattab, HRamirez, LFRisperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacol. Bull. 1996;32(1):55–61.Google ScholarPubMed
Segal, JBerk, MBrook, SRisperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin. Neuropharmacol. 1998;21(3):176–180.Google ScholarPubMed
Sharma, VPistor, LTreatment of bipolar mixed state with olanzapine. J. Psychiatry Neurosci. 1999;24(1):40–44.Google ScholarPubMed
Shi, LNamjoshi, MAZhang, FGandhi, GEdgell, ETTohen, M, et al.Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int. Clin. Psychopharmacol. 2002;17(5):227–237.CrossRefGoogle ScholarPubMed
Schnierow, BJGraeber, DAManic symptoms associated with initiation of risperidone. Am. J. Psychiatry 1996;153(9):1235–1236.Google ScholarPubMed
Soutullo, CASorter, MTFoster, KDMcElroy, SLKeck, PEOlanzapine in the treatment of adolescent acute mania: a report of seven cases. J. Affect. Disord. 1999;53(3):279–283.CrossRefGoogle ScholarPubMed
Spitzer, REndicott, JSchedule for affective disorders and schizophrenia: change version. 3rd ed., New York: Biometrics Research, New York State Psychiatric Institute; 1978.Google Scholar
Suppes, TWebb, APaul, BCarmody, TKraemer, HRush, AJClinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am. J. Psychiatry 1999;156(8):1164–1169.Google Scholar
Tohen, MZarate, CA Jr.Centorrino, FHegarty, JIFroeschl, MZarate, SBRisperidone in the treatment of mania. J. Clin. Psychiatry 1996;57(6):249–253.Google ScholarPubMed
Tohen, MChengappa, KNSuppes, TZarate, CA Jr.Calabrese, JRBowden, CL, et al.Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially non-responsive to valproate or lithium monotherapy. Arch. Gen. Psychiatry 2002;59(1):62–69.CrossRefGoogle ScholarPubMed
Tohen, MJacobs, TGGrundy, SLMcElroy, SLBanov, MCJanicak, PGet al.Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch. Gen. Psychiatry 2000;57(9):841–849.CrossRefGoogle Scholar
Tohen, MSanger, TMMcElroy, SLTollefson, GDChengappa, KNDaniel, DGet al.Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am. J. Psychiatry 1999;156(5):702–709.Google ScholarPubMed
Vieta, EHerraiz, MParramon, GGoikolea, JMFernandez, ABenabarre, ARisperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain. J. Affect. Disord. 2002;72(1):15–19.CrossRefGoogle Scholar
Vieta, EParramon, GPadrell, ENieto, EMartinez-Aran, ACorbella, Bet al.Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord. 2002;4(5):335–340.CrossRefGoogle ScholarPubMed
Weisler, RHAhearn, EPDavidson, JRWallace, CDAdjunctive use of olanzapine in mood disorders: five case reports. Ann. Clin. Psychiatry 1997;9(4):259–262.CrossRefGoogle ScholarPubMed
Yatham, LNGrossman, FAugustyns, IVieta, ERavindran, AMood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br. J. Psychiatry 2003;182:141–147.CrossRefGoogle ScholarPubMed
Young, RCBiggs, JTZiegler, VEMeyer, DAA rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978;133:429–435.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.